Cervical Neoplasia Incidence After HPV Vaccination
Decreases in cervical intraepithelial neoplasia (CIN) on the population level among patients vaccinated for the human papillomavirus (HPV) should be considered.
Diagnosis & Disease Information
Parents Support Mandatory School-entry HPV Vaccination With Opt-out Provisions
Only 1 in 5 parents support laws requiring human papillomavirus (HPV) vaccination for school attendance.
Immunogenicity of HPV Vaccination With 1 to 3 Doses Assessed
Researchers found that vaccination for HPV should be given in 2 doses, at least 6 months apart for routine vaccinations of young girls.
HPV Vaccine Still Effective with Fewer Than Three Doses
The human papillomavirus (HPV)-16/18 vaccine appears to protect against the viral strain even after one or two doses.
Many Students Mistakenly Believe HPV Risk is Low
Many American college students don’t fully understand the threat posed by the human papillomavirus (HPV) or their risk for infection.
HPV Vaccination in Females May Indirectly Benefit Males
Males benefit indirectly when girls are immunized against human papillomavirus (HPV).
In Teen Boys, HPV4 Vaccine Cost-Effective for Oropharyngeal Prevention
The quadrivalent human papillomavirus (HPV4) vaccine appears to be cost-effective for the prevention of oropharyngeal cancer (OPC).
Challenges in Oropharyngeal Cancer Identified
Mixed views in relation to explaining causal role of human papillomavirus (HPV) in oropharyngeal cancer.
Promising HPV Vaccine Receives Development Funding from the National Cancer Institute
The National Cancer Institute (NCI) has funded $3.5 million for the development of a new human papillomavirus (HPV) vaccine.
For HPV-Associated Anal Cancer, ADXS-HPV Immunotherapy May Be Effective
Results of ADXS-HPV with standard chemo and radiotherapy for HPV-associated anal cancer who have a high risk of recurrence.
- Loading...
Loading...
Next post in Gastrointestinal Cancers
Loading... 
Loading...